191 related articles for article (PubMed ID: 12538324)
1. Successful radioiodine treatment in a 3 year old child with Graves' disease following antithyroid medication induced neutropenia.
Rahman MA; Birrell G; Stewart H; Lucraft H; Cheetham TD
Arch Dis Child; 2003 Feb; 88(2):158-9. PubMed ID: 12538324
[TBL] [Abstract][Full Text] [Related]
2. Outcome of pediatric Graves' disease after treatment with antithyroid medication and radioiodine.
Ward L; Huot C; Lambert R; Deal C; Collu R; Van Vliet G
Clin Invest Med; 1999 Aug; 22(4):132-9. PubMed ID: 10497711
[TBL] [Abstract][Full Text] [Related]
3. Influence of prior carbimazole on the outcome of radioiodine therapy in pediatric and adolescent Graves' disease.
Ballal S; Soundararajan R; Singh H; Garg A; Chopra S; Bal C
Nucl Med Commun; 2015 Jun; 36(6):566-72. PubMed ID: 25757198
[TBL] [Abstract][Full Text] [Related]
4. The effect of propylthiouracil on subsequent radioactive iodine therapy in Graves' disease.
Hancock LD; Tuttle RM; LeMar H; Bauman J; Patience T
Clin Endocrinol (Oxf); 1997 Oct; 47(4):425-30. PubMed ID: 9404440
[TBL] [Abstract][Full Text] [Related]
5. Carbimazole embryopathy: implications for the choice of antithyroid drugs in pregnancy.
Bowman P; Osborne NJ; Sturley R; Vaidya B
QJM; 2012 Feb; 105(2):189-93. PubMed ID: 21258054
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcome of thyrotoxicosis in childhood and adolescence in the west of Scotland: the case for long-term antithyroid treatment and the importance of initial counselling.
Kourime M; McGowan S; Al Towati M; Ahmed SF; Stewart G; Williamson S; Hunter I; Donaldson MDC
Arch Dis Child; 2018 Jul; 103(7):637-642. PubMed ID: 29269558
[TBL] [Abstract][Full Text] [Related]
7. Graves' disease in a 3 year-old patient with agranulocytosis due to anti-thyroid drugs: Radioiodine ablation therapy as an effective alternative.
Espinosa-Muñoz E; Ramírez-Ocaña D; Martín-García AM; Ruiz-García FJ; Puentes-Zarzuela C
Rev Esp Med Nucl Imagen Mol; 2017; 36(4):260-262. PubMed ID: 28392335
[TBL] [Abstract][Full Text] [Related]
8. High dose of (131)I therapy for the treatment of hyperthyroidism caused by Graves' disease.
Alexander EK; Larsen PR
J Clin Endocrinol Metab; 2002 Mar; 87(3):1073-7. PubMed ID: 11889166
[TBL] [Abstract][Full Text] [Related]
9. Radioiodine therapy in Graves' disease patients with large diffuse goiters treated with or without carbimazole at the time of radioiodine therapy.
Sabri O; Zimny M; Schreckenberger M; Reinartz P; Ostwald E; Buell U
Thyroid; 1999 Dec; 9(12):1181-8. PubMed ID: 10646656
[TBL] [Abstract][Full Text] [Related]
10. [A serious adverse effect: sepsis due to carbimazole].
Guardiola PD; Tenreiro AP
Endocrinol Nutr; 2009; 56(7):378-80. PubMed ID: 19883898
[TBL] [Abstract][Full Text] [Related]
11. Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves' disease.
Harper L; Chin L; Daykin J; Allahabadia A; Heward J; Gough SC; Savage CO; Franklyn JA
Clin Endocrinol (Oxf); 2004 Jun; 60(6):671-5. PubMed ID: 15163328
[TBL] [Abstract][Full Text] [Related]
12. [Two cases of serious hepatic injury caused by antithyroid drugs].
Grzywa M; Orłowska-Florek R; Grzywa-Celińska A
Endokrynol Pol; 2009; 60(5):396-400. PubMed ID: 19885811
[TBL] [Abstract][Full Text] [Related]
13. Thionamides alter the efficacy of radioiodine treatment in patients with Graves' disease.
Koroscil TM
South Med J; 1995 Aug; 88(8):831-6. PubMed ID: 7631208
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of a patient with Graves' disease on hemodialysis complicated by antithyroid drug-induced granulocytopenia and angina pectoris.
Miyasaka Y; Yoshimura M; Tabata S; Shozu A; Nishikawa M; Iwasaka T; Inada M
Thyroid; 1997 Aug; 7(4):621-4. PubMed ID: 9292952
[TBL] [Abstract][Full Text] [Related]
15. One-year follow-up of Graves' disease treatment by four different protocols of radioiodine administration.
Calegaro JU; De Freitas Gomes E; Bae SH; Ulyssea R; Casulari LA
Panminerva Med; 2000 Dec; 42(4):241-5. PubMed ID: 11294085
[TBL] [Abstract][Full Text] [Related]
16. Management of a pregnant patient with Graves' disease complicated by thionamide-induced neutropenia in the first trimester.
Davison S; Lennard TW; Davison J; Kendall-Taylor P; Perros P
Clin Endocrinol (Oxf); 2001 Apr; 54(4):559-61. PubMed ID: 11318795
[TBL] [Abstract][Full Text] [Related]
17. The effect of antithyroid drug pretreatment on acute changes in thyroid hormone levels after (131)I ablation for Graves' disease.
Burch HB; Solomon BL; Cooper DS; Ferguson P; Walpert N; Howard R
J Clin Endocrinol Metab; 2001 Jul; 86(7):3016-21. PubMed ID: 11443161
[TBL] [Abstract][Full Text] [Related]
18. Thyrotoxicosis.
Franklyn J
Clin Med (Lond); 2003; 3(1):11-5. PubMed ID: 12617406
[No Abstract] [Full Text] [Related]
19. Low failure rate of fixed administered activity of 400 MBq 131I with pre-treatment with carbimazole for thyrotoxicosis: the Gateshead Protocol.
Razvi S; Basu A; McIntyre EA; Wahid ST; Bartholomew PH; Weaver JU;
Nucl Med Commun; 2004 Jul; 25(7):675-82. PubMed ID: 15208494
[TBL] [Abstract][Full Text] [Related]
20. Different strategies to overcome the effect of carbimazole on high- and low-dose radioiodine therapy: results from continuous dose-effect models.
Walter MA; Schindler C; Christ-Crain M; Müller-Brand J; Müller B
Eur J Clin Invest; 2009 Jan; 39(1):51-7. PubMed ID: 19087129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
